Abstract Background Relapsed most of the GDP based cycles were administered with ease on day care basis. Use of Carboplatin instead of Cisplatin does not require aggressive hydration, increasing ease of administration and shortens time duration. These benefits positively influenced patient quality of life and healthcare utilization. Conclusion GDP-based chemotherapy, with or without targeted agents, is an effective, cost-efficient, and patient-friendly salvage regimen for R/R lymphoma. It facilitates high CR and transplant rates—especially in HL—with manageable toxicity. The regimen's daycare feasibility and reduced hospitalization needs offer significant quality-of-life and economic advantages. Substituting Carboplatin for Cisplatin further enhances administration convenience.
Nair et al. (Mon,) studied this question.